Your browser doesn't support javascript.
loading
Betaine supplementation improves positive symptoms in schizophrenia.
Kirihara, Kenji; Fujioka, Mao; Suga, Motomu; Kondo, Shinsuke; Ichihashi, Kayo; Koshiyama, Daisuke; Morita, Kentaro; Ikegame, Tempei; Tada, Mariko; Araki, Tsuyoshi; Jinde, Seiichiro; Taniguchi, Kazuki; Hosokawa, Taiga; Sugishita, Kazuyuki; Dogan, Shinjiro; Marumo, Kohei; Itokawa, Masanari; Kasai, Kiyoto.
Afiliação
  • Kirihara K; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Disability Services Office, The University of Tokyo, Tokyo, Japan. Electronic address: kirihara-tky@g.ecc.u-tokyo.ac.jp.
  • Fujioka M; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Suga M; Department of Clinical Psychology, Teikyo Heisei University, Tokyo, Japan.
  • Kondo S; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ichihashi K; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Koshiyama D; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Morita K; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Rehabilitation, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ikegame T; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Tada M; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Office for Mental Health Support, Center for Research on Counseling and Support Services, The University of Tokyo, Tokyo, Japan.
  • Araki T; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Psychiatry, Teikyo University Hospital, Mizonokuchi, Kawasaki, Japan.
  • Jinde S; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Taniguchi K; UTokyo Clinical and Research Innovation Network for Psychiatry, Tokyo, Japan; Higashiomiya Mental Clinic, Saitama, Japan.
  • Hosokawa T; UTokyo Clinical and Research Innovation Network for Psychiatry, Tokyo, Japan; Stress Care Tokyo Ueno Ekimae Clinic, Tokyo, Japan.
  • Sugishita K; UTokyo Clinical and Research Innovation Network for Psychiatry, Tokyo, Japan; Oji Mental Clinic, Tokyo, Japan.
  • Dogan S; UTokyo Clinical and Research Innovation Network for Psychiatry, Tokyo, Japan; Toyocho Mental Clinic, Tokyo, Japan.
  • Marumo K; UTokyo Clinical and Research Innovation Network for Psychiatry, Tokyo, Japan; Hongo Todaimae Mental Clinic, Tokyo, Japan.
  • Itokawa M; Project for Schizophrenia Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan; Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan.
  • Kasai K; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; University of Tokyo Institute for Diversity & Adaptation of Human Mind (UTIDAHM), Tokyo, Japan; University of Tokyo Center for Integrative Science of Human Behavior (CiSHuB), Tokyo, Japan; The Inte
Schizophr Res ; 250: 120-122, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36401992
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Betaína Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Betaína Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article